Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Catherine Estrampes currently holds 23,573 shares of GE HealthCare Technologies Inc. (GEHC), valued at approximately $0. This represents their equity stake as Chief Commer. & Growth Officer.
Based on SEC Form 4 filings, Catherine Estrampes has been a net neutral trader of GEHC stock. They have purchased $0 and sold $0 worth of shares.
Catherine Estrampes's most recent insider trade was on Sep 3, 2026, when they sold 508 shares at $70.56 per share.
Catherine Estrampes serves as Chief Commer. & Growth Officer at GE HealthCare Technologies Inc. (GEHC). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Catherine Estrampes holds the position of Chief Commer. & Growth Officer at GE HealthCare Technologies Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Catherine Estrampes has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Catherine Estrampes was on Sep 3, 2026, when they sold $35.8K worth of GEHC shares. This transaction involved 508 shares at $70.56 per share.
Catherine Estrampes currently owns 23,573 shares of GE HealthCare Technologies Inc. (GEHC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Catherine Estrampes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Catherine Estrampes has 1 Form 4 filings on record as an insider at GE HealthCare Technologies Inc..
Set alerts for Catherine Estrampes and 40,000+ other insiders.